The DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Open accessAbstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current treatment strategy for COPD includes inhaled corticosteroids, anticholinergics, and β2-agonists, which have been primarily effective in controlling the symptoms but do not cure the underlying disease.184”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,410
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationSpruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citationJones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A. R., Locantore, N., Müllerová, H., Tal‐Singer, R., Miller, B. E., Lomas, D. A., Agustí, A. G. N., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,983
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citationAntibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
Anthonisen, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,474
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,364
Research works printed but not linked: 34
- Medical Research Council Committee on the Aetiology of Chronic Bronchitis, 1965, Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis, Lancet, 1, 775
- Fletcher, 1960, Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score), BMJ, 2, 1662
- National Institute for Health and Care Excellence, 2016, Multimorbidity: clinical assessment and management, in press
- 1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
- van Eerd, 2016, Smoking cessation for people with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD010744
- van der Meer, 2003, Smoking cessation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002999
- McNeill, 2015, E-cigarettes: an evidence update
- McRobbie, 2014, Electronic cigarettes for smoking cessation and reduction, Cochrane Database Syst Rev, 12, CD010216
- Cahill, 2013, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst Rev, 5, CD009329
- Stead, 2013, Physician advice for smoking cessation, Cochrane Database Syst Rev, 5, CD000165
- Stead, 2016, Combined pharmacotherapy and behavioural interventions for smoking cessation, Cochrane Database Syst Rev, 3, CD008286
- Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733
- Wongsurakiat, 2003, Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients, J Med Assoc Thai, 86, 497
- Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1
- Appleton, 2006, Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD006101
- Karner, 2014, Tiotropium versus placebo for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD009285
- Ram, 2002, Oral theophylline for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003902
- Nannini, 2012, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 9, CD006829
- Nannini, 2013, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 8, CD006826
- Yang, 2012, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD002991
- Chong, 2013, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 11, CD002309
- Poole, 2015, Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001287
- Puhan, 2011, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD005305
- Kruis, 2013, Integrated disease management interventions for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10, CD009437
- Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
- Cranston, 2005, Domiciliary oxygen for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001744
- Barr, 2005, Inhaled tiotropium for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002876
- Karner, 2012, Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 4, CD008989
- Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822
- Tiong, 2006, Lung volume reduction surgery for diffuse emphysema, Cochrane Database Syst Rev, CD001001
- Vollenweider, 2012, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 12, CD010257
- Ram, 2006, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD004403
- Schuetz, 2012, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev, CD007498
- Bradley, 1985, Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome, Am Rev Respir Dis, 131, 835
Cited by
Sorted by citations
Items 301–400 of 1,001
The Emerging Role of Radiomics in COPD and Lung Cancer
Refaee, T., Wu, G., Ibrahim, A., Halilaj, I., Leijenaar, R. T. H., Rogers, W., Gietema, H. A., Hendriks, L. E. L., Lambin, P., & Woodruff, H. C. (2020) · Respiration · doi:10.1159/000505429 · Cited by 50
Zhang, W., Sheridan, S. C., Birkhead, G. S., Croft, D. P., Brotzge, J. A., Justino, J., Stuart, N. A., Du, Z., Romeiko, X. X., Ye, B., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.05.555 · Cited by 49
Gao, X., Coull, B. A., Lin, X., Vokonas, P., Sparrow, D., Hou, L., DeMeo, D. L., Litonjua, A. A., Schwartz, J. D., & Baccarelli, A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10350 · Cited by 50
Immunomodulatory role of oral microbiota in inflammatory diseases and allergic conditions
Moreno, C. M., Boeree, E., Freitas, C. M. T., & Weber, K. S. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1067483 · Cited by 53
Macrophage Polarization and Functions in Pathogenesis of Chronic Obstructive Pulmonary Disease
Kim, G.-D., Lim, E. Y., & Shin, H. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115631 · Cited by 56
Kaireit, T. F., Gutberlet, M., Voskrebenzev, A., Freise, J., Welte, T., Hohlfeld, J. M., Wacker, F. K., & Vogel‐Claussen, J. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25902 · Cited by 49
Association of lung function with cardiovascular risk: a cohort study
Wang, B., Zhou, Y., Xiao, L., Guo, Y., Ma, J., Zhou, M., Shi, T., Tan, A., Yuan, J., & Chen, W. (2018) · Respiratory Research · doi:10.1186/s12931-018-0920-y · Cited by 49
Bodduluri, S., Nakhmani, A., Reinhardt, J. M., Wilson, C. G., McDonald, M., Rudraraju, R., Jaeger, B. C., Bhakta, N. R., Castaldi, P. J., Sciurba, F. C., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132781 · Cited by 49
Zheng, L., Jiang, Y., Fei, J., Cao, P., Zhang, C., Xie, G.-F., Wang, L., Cao, W., Fu, L., & Zhao, H. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112164 · Cited by 49
Interstitial Lung Abnormalities and the Clinical Course in Patients With COPD
Lee, T. S., Jin, K. N., Lee, H. W., Yoon, S.-Y., Park, T. Y., Heo, E. Y., Kim, D. K., Chung, H. S., & Lee, J. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.08.017 · Cited by 48
Li, X., Tang, X., Wang, R., Xue, Y., Zhao, Y. Q., Wang, L., Li, H., Chu, H., Li, J., Mao, W., et al. (2020) · International Journal of COPD · doi:10.2147/copd.s283020 · Cited by 48
Short, B., Carson, S., Devlin, A., Reihill, J. A., Crilly, A., Mackay, W. G., Ramage, G., Williams, C., Lundy, F. T., McGarvey, L. P., et al. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1863330 · Cited by 48
Protective role of zinc in the pathogenesis of respiratory diseases
Luan, R., Ding, D., Xue, Q., Li, H., Wang, Y., & Yang, J. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01191-6 · Cited by 48
Mou, K., Chan, S. M. H., & Vlahos, R. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108635 · Cited by 53
Small Airway Disease in Patients with Chronic Obstructive Pulmonary Disease
Singh, D. (2017) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2017.0080 · Cited by 53
Self-citationRamírez‐Venegas, A., Velázquez-Uncal, M., Pérez-Hernández, R., Guzmán-Bouilloud, N. E., Falfán‐Valencia, R., Mayar-Maya, M. E., Aranda-Chávez, A., & Sansores, R. H. (2018) · International Journal of COPD · doi:10.2147/copd.s156409 · Cited by 50
Oelsner, E. C., Ortega, V. E., Smith, B. M., Nguyen, J. N., Manichaikul, A. W., Hoffman, E. A., Guo, X., Taylor, K. D., Woodruff, P. G., Couper, D. J., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201812-2355oc · Cited by 49
Self-citationResveratrol and metabolic health in COPD: A proof-of-concept randomized controlled trial
Beijers, R. J. H. C. G., Gosker, H. R., Sanders, K. J. C., de Theije, C. C., KELDERS, M. C. J. M., Clarke, G. A., Cryan, J. F., van den Borst, B., & Schols, A. M. W. J. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.01.002 · Cited by 48
Balasubramanian, A., Kolb, T. M., Damico, R. L., Hassoun, P. M., McCormack, M. C., & Mathai, S. C. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.047 · Cited by 49
A randomised trial of a web-based physical activity self-management intervention in COPD
Robinson, S. A., Cooper, J. A., Goldstein, R. L., Polak, M. M., Rivera, P. N. C., GAGNON, D. R., Samuelson, A., Moore, S., Kadri, R., Richardson, C. R., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00158-2021 · Cited by 48
Oral microbial dysbiosis in patients with periodontitis and chronic obstructive pulmonary disease
Liu, S., Xie, G., Chen, M., He, Y., Yu, W., Chen, X., Mao, W., Liu, N., Zhang, Y., Chang, Q., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1121399 · Cited by 47
Labaki, W. W., Gu, T., Murray, S., Curtis, J. L., Wells, J. M., Bhatt, S. P., Bon, J. M., Díaz, A. A., Hersh, C. P., Wan, E. S., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202210-1887oc · Cited by 49
Russian guidelines for the management of COPD: algorithm of pharmacologic treatment
Айсанов, З. Р., Avdeev, S. N., Arkhipov, V. V., Belevskiy, А. S., Чучалин, А. Г., Викторович, Л. И., Si, O., Shmelev, E., & Miravitlles, M. (2018) · International Journal of COPD · doi:10.2147/copd.s153770 · Cited by 47
Richmond, B. W., Du, R., Han, W., Benjamin, J. T., van der Meer, R., Gleaves, L. A., Guo, M., McKissack, A., Zhang, Y., Cheng, D., et al. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0329oc · Cited by 46
de Blasio, F., Scalfi, L., Gregorio, A. D., Alicante, P., Bianco, A., Tantucci, C., Bellofiore, B., & Blasio, F. D. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.01.001 · Cited by 46
Ostridge, K., Gove, K., Paas, K. H. W., Burke, H., Freeman, A. T., Harden, S. P., Kirby, M., Peterson, S., Sieren, J., McCrae, C., et al. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201810-669oc · Cited by 47
Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD)
Cruz, T., López-Giraldo, A., Noell, G. G., Casas-Recasens, S., Garcia, T., Molins, L., Juan, M., Fernández, M. A., Agustí, A. G. N., & Faner, R. (2019) · Respiratory Research · doi:10.1186/s12931-019-1105-z · Cited by 47
Self-citationInhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
Price, D. B., Voorham, J., Brusselle, G., Clemens, A., Κostikas, Κ., Stephens, J. W., Park, H. Y., Roche, N., & Fogel, R. (2019) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-019-0150-x · Cited by 47
Self-citationPavitt, M. J., Tanner, R., Lewis, A. P., Buttery, S. C., Mehta, B., Jefford, H., Curtis, K., BANYA, W. A. S., Husain, S., Satkunam, K., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214278 · Cited by 44
Sex Differences in Airways at Chest CT: Results from the COPDGene Cohort
Bhatt, S. P., Bodduluri, S., Nakhmani, A., Kim, Y.-I., Reinhardt, J. M., Hoffman, E. A., Motahari, A., Wilson, C. G., Humphries, S. M., Regan, E. A., et al. (2022) · Radiology · doi:10.1148/radiol.212985 · Cited by 46
Chung, C., Lee, J. W., Lee, S. W., & Jo, M. (2024) · JMIR mhealth and uhealth · doi:10.2196/41753 · Cited by 50
The role of tele-medicine in patients with respiratory diseases
Ambrosino, N., & Fracchia, C. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1383898 · Cited by 48
Burkart, K. M., Sofer, T., London, S. J., Manichaikul, A. W., Hartwig, F. P., Yan, Q., Artigas, M. S., Ávila, L., Chen, W., Thomas, S., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1493oc · Cited by 46
Feasibility and challenges of using multiple breath washout in COPD
Bell, A., Lawrence, P. J., Singh, D., & Horsley, A. R. (2018) · International Journal of COPD · doi:10.2147/copd.s164285 · Cited by 47
Self-citationAugustin, I. M. L., Spruit, M. A., Houben‐Wilke, S., Franssen, F. M. E., Vanfleteren, L. E. G. W., Gaffron, S., Janssen, D. J. A., & Wouters, E. F. �. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201593 · Cited by 46
Halper‐Stromberg, E., Yun, J. H., Parker, M. M., Tal‐Singer, R., Gaggar, A., Silverman, E. K., Leach, S. M., Bowler, R. P., & Castaldi, P. J. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0373oc · Cited by 45
Synn, A. J., Li, W., Estépar, R. S. J., Zhang, C., Washko, G. R., O’Connor, G. T., Araki, T., Hatabu, H., Bankier, A. A., Mittleman, M. A., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00408-2019 · Cited by 46
Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality
Young, K. A., Regan, E. A., Han, M. K., Lutz, S. M., Ragland, M. F., Castaldi, P. J., Washko, G. R., Cho, M. H., Strand, M. J., Curran‐Everett, D., et al. (2019) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.6.5.2019.0150 · Cited by 47
The Effect of Adaptive Learning Rate on the Accuracy of Neural Networks
Jepkoech, J., Mugo, D. M., Kenduiywo, B. K., & Too, E. C. (2021) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2021.0120885 · Cited by 56
Wang, K., Liao, Y., Li, X., Wang, R., Zeng, Z., Cheng, M., Gao, L., Xu, D., Wen, F., Wang, T., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109537 · Cited by 45
Vitamin K deficiency: the linking pin between COPD and cardiovascular diseases?
Piscaer, I., Wouters, E. F. �., Vermeer, C., Janssens, W., Franssen, F. M. E., & Janssen, R. (2017) · Respiratory Research · doi:10.1186/s12931-017-0673-z · Cited by 45
Oelsner, E. C., Smith, B. M., Hoffman, E. A., Kalhan, R., Donohue, K. M., Kaufman, J. D., Nguyen, J. N., Manichaikul, A. W., Rotter, J. I., Michos, E. D., et al. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201710-820oc · Cited by 45
Kim, J., Kim, D. Y., Heo, H.-R., Choi, S. S., Hong, S., & Kim, W. J. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.07.55 · Cited by 45
Treating Hypertension in Chronic Obstructive Pulmonary Disease
Finks, S. W., Rumbak, M. J., & Self, T. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1805377 · Cited by 45
Chen, L., Chen, L., Zheng, H., Wu, S., & Wang, S. (2021) · Chronic Respiratory Disease · doi:10.1177/14799731211060051 · Cited by 45
Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease
Rivas, M., Gupta, G., Costanzo, L., Ahmed, H., Wyman, A. E., & Geraghty, P. M. (2022) · Medicina · doi:10.3390/medicina58060817 · Cited by 47
Cangemi, R., Falcone, M., Taliani, G., Calvieri, C., Tiseo, G., Romiti, G. F., Bertazzoni, G., Farcomeni, A., & Violi, F. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201806-419oc · Cited by 44
Ribeiro, C. O., Faria, Á. C. D., Lopes, A. J., & de Melo, P. L. (2018) · International Journal of COPD · doi:10.2147/copd.s173686 · Cited by 44
Improving Detection of Early Chronic Obstructive Pulmonary Disease
Labaki, W. W., & Han, M. K. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201808-529mg · Cited by 44
Geidl, W., Carl, J., Cassar, S., Lehbert, N., Mino, E., Wittmann, M., Wagner, R., Schultz, K., & Pfeifer, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091346 · Cited by 48
Waschki, B., Alter, P. J., Zeller, T., Magnussen, C., Neumann, F., Twerenbold, R., Sinning, C., Herr, C., Kahnert, K., Fähndrich, S., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01314-2019 · Cited by 45
Self-citationInteraction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function
Kim, W., Moll, M. R., Qiao, D., Hobbs, B. D., Shrine, N. R. G., Sakornsakolpat, P., Tobin, M. D., Dudbridge, F., Wain, L. V., Ladd‐Acosta, C., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.39525 · Cited by 43
Kelly, N., Winning, L., Irwin, C., Lundy, F. T., Linden, D. A., McGarvey, L. P., Linden, G. J., & Karim, I. A. E. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01757-z · Cited by 46
Rosińćzuk, J., Przyszlak, M., & Uchmanowicz, I. (2018) · International Journal of COPD · doi:10.2147/copd.s165714 · Cited by 43
Schreiber, A. F., Cemmi, F., Ambrosino, N., Ceriana, P., Lastoria, C., & Carlucci, A. (2018) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2018.1500533 · Cited by 42
Biaoxue, R., Liu, Y., Li, M., Fu, T., Gao, W., & Liu, H. (2018) · International Journal of COPD · doi:10.2147/copd.s177034 · Cited by 43
Oelsner, E. C., Balte, P., Grams, M. E., Cassano, P. A., Jacobs, D. R., Barr, R. G., Burkart, K. M., Kalhan, R., Kronmal, R. A., Loehr, L. R., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201803-0402oc · Cited by 43
Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study
Chin, A. T., Rylance, J., Makumbirofa, S., Meffert, S., Vu, T. A., Clayton, J., Mason, P. R., Woodruff, P. G., & Metcalfe, J. Z. (2019) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.18.0313 · Cited by 43
Palliative Care Approach to Chronic Diseases
Mechler, K., & Liantonio, J. (2019) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2019.05.008 · Cited by 50
Trevisan, C., Rizzuto, D., Maggi, S., Sergi, G., Welmer, A., & Vetrano, D. L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111901 · Cited by 43
Zhou, Y., Yan, T., Zhou, X., Cao, P., Luo, C., Zhou, L., Xu, Y., Liu, Y., Xue, J., Wang, J., et al. (2019) · Strahlentherapie und Onkologie · doi:10.1007/s00066-019-01552-4 · Cited by 43
The effect of exacerbation history on outcomes in the IMPACT trial
Halpin, D. M. G., Dransfield, M. T., Han, M. K., Jones, C. E., Kilbride, S., Lange, P., Lipson, D. A., Lomas, D. A., Martínez, F. J., Pascoe, S., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01921-2019 · Cited by 43
Self-citationAhmadi, A., Eftekhari, M. H., Mazloom, Z., Masoompour, M., Fararouei, M., Eskandari, M. H., Mehrabi, S., Bedeltavana, A., Famouri, M. L., Zare, M., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01466-1 · Cited by 43
Guo, Y., Xing, Z., Shan, G., Janssens, J.-P., Sun, T., Chai, D., Liu, W., Wang, Y., Ma, Y., Tong, Y., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.581763 · Cited by 43
Epithelium-derived IL17A Promotes Cigarette Smoke–induced Inflammation and Mucus Hyperproduction
Wu, M., Lai, T., Jing, D., Yang, S., Wu, Y., Li, Z., Wu, Y., Zhao, Y., Zhou, L., Chen, H., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0424oc · Cited by 43
Zhang, H., Liu, B., Jiang, S., Wu, J., Qi, C., Mohammadtursun, N., Li, Q., Li, L., Zhang, H., Sun, J., et al. (2021) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.102061 · Cited by 43
López‐Cano, C., Ciudin, A., Sánchez, E., Tinahones, F. J., Barbé, F., Dalmases, M., García‐Ramírez, M., Soto, A., Gaeta, A. M., Pellitero, S., et al. (2021) · Diabetes · doi:10.2337/db21-0688 · Cited by 43
Zhang, P., Chen, B., Lou, H., Zhu, Y., Chen, P., Dong, Z., Zhu, X., Li, T., & Lou, P. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01780-4 · Cited by 43
Divo, M. J., Marín, J. M., Casanova, C., López, C. C., Pinto-Plata, V., Marín‐Oto, M., Polverino, F., de-Torres, J. P., Billheimer, D. D., Celli, B. R., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02191-7 · Cited by 46
Self-citationThe interplay between oxidative stress and autophagy in chronic obstructive pulmonary disease
Zhao, X., Zhang, Q., & Zheng, R. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1004275 · Cited by 48
Lung and Gut Microbiome in COPD
Karakasidis, E., Kotsiou, O. S., & Gourgoulianis, K. I. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050804 · Cited by 46
Eosinophils promote pulmonary matrix destruction and emphysema via Cathepsin L
Xu, X., Yu, T., Dong, L.-L., Glauben, R., Wu, S., Huang, R., Qumu, S., Chang, C., Guo, J., Pan, L., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01634-x · Cited by 45
Roy, A., & Satija, U. (2024) · IEEE/ACM Transactions on Audio Speech and Language Processing · doi:10.1109/taslp.2024.3393743 · Cited by 42
Tsiligianni, I., Mezzi, K., Fucile, S., Κostikas, Κ., Shen, S., Banerji, D. D., & Fogel, R. (2017) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2017.1324837 · Cited by 42
Obesity modulates diaphragm curvature in subjects with and without COPD
Boriek, A. M., Lopez, M. A., Velasco, C., Bakir, A. A., Frolov, A., Wynd, S., Babb, T. G., Hanania, N. A., Hoffman, E. A., & Sharafkhaneh, A. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00173.2017 · Cited by 43
A Novel Murine Chronic Obstructive Pulmonary Disease Model and the Pathogenic Role of MicroRNA-21
He, S., Li, L., Sun, S., Zeng, Z., Lu, J., & Xie, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00503 · Cited by 42
Swallow and Aspiration in Chronic Obstructive Pulmonary Disease
Cvejic, L., & Bardin, P. G. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201804-0704pp · Cited by 43
Baker, E., & Fatoye, F. (2018) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2018.12.004 · Cited by 42
Regenerative pharmacology for COPD: breathing new life into old lungs
Ng-Blichfeldt, J.-P., Gosens, R., Dean, C. H., Griffiths, M., & Hind, M. D. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212630 · Cited by 44
Update in Chronic Obstructive Pulmonary Disease 2019
Alter, P. J., Baker, J. R., Dauletbaev, N., Donnelly, L., Pistenmaa, C. L., Schmeck, B., Washko, G. R., & Vogelmeier, C. F. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0370up · Cited by 42
Self-citationXia, J., Sun, L., Xu, S., Qiu, X. Y., Zhao, J., Xiong, W., Xu, Y., & Chu, S. (2020) · International Journal of COPD · doi:10.2147/copd.s271237 · Cited by 44
Blervaque, L., PREFAUT, C. G., Forthin, H., Maffre, F., Bourrelier, M., Héraud, N., Catteau, M., Pomiès, P., Jaffuel, D., Molinari, N., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01674-3 · Cited by 52
Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics
Artzy‐Schnirman, A., Raviv, S. A., Doppelt‐Flikshtain, O., Shklover, J., Korin, N., Gross, A., Mizrahi, B., Schroeder, A., & Sznitman, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113901 · Cited by 45
Zinellu, E., Zinellu, A., Fois, A. G., Pau, M. C., Scano, V., Piras, B., Carru, C., & Pirina, P. (2021) · Antioxidants · doi:10.3390/antiox10050710 · Cited by 41
Cornelli, U., Casella, C., Belcaro, G. V., Cesarone, M. R., Marucci, S., Rondanelli, M., Recchia, M., & Zanoni, G. (2025) · Microplastics · doi:10.3390/microplastics4040093 · Cited by 46
Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross‐over trial
McKinstry, S., Pilcher, J., Bardsley, G., Berry, J., van de Hei, S. J., Braithwaite, I. E., Fingleton, J., Weatherall, M., & Beasley, R. W. (2017) · Respirology · doi:10.1111/resp.13185 · Cited by 41
Resveratrol for patients with chronic obstructive pulmonary disease
Beijers, R. J. H. C. G., Gosker, H. R., & Schols, A. M. W. J. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000444 · Cited by 41
Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study
Herrera, A. C., de, M. M., Menezes, A. M. B., Wehrmeister, F. C., Varela, M. V. L., I, L. M., Ramírez, L., & Miravitlles, M. (2018) · International Journal of COPD · doi:10.2147/copd.s154097 · Cited by 41
Formiga, M. F., Roach, K. E., Vital, I., Urdaneta, G., Balestrini, K., Candelario, R. A. C., Campos, M., & Cahalin, L. P. (2018) · International Journal of COPD · doi:10.2147/copd.s160512 · Cited by 42
Which Physicians Are Taking Care of People With COPD?
Cho, E. E., Mecredy, G. C., Wong, H. H., Stanbrook, M. B., & Gershon, A. S. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.12.018 · Cited by 41
Robinson, S. A., Shimada, S. L., Quigley, K. S., & Moy, M. L. (2019) · Journal of Behavioral Medicine · doi:10.1007/s10865-019-00042-3 · Cited by 41
Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study
Ierodiakonou, D., Kampouraki, M., Poulonirakis, I., Papadokostakis, P., Lintovoi, E., Karanassos, D., Maltezis, K., Chorti, M. S., Petrovitsos, E., Dimopoulou, S., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0824-8 · Cited by 41
Lan, Y., Yang, J.-C., Yen, C., Huang, T., Chen, Y.-C., Chen, H., Chong, K., & Chen, C. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1282-1 · Cited by 41
Emphysema phenotypes and lung cancer risk
González, J., Henschke, C. I., Yankelevitz, D. F., Seijo, L. M., Reeves, A. P., Yip, R., Xie, Y., Chung, M., Sánchez-Salcedo, P., Alcaide, A. B., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219187 · Cited by 41
Zhao, J., Pu, J., Hao, B., Huang, L., Chen, J., Wei, H., Zhou, Y., Li, B., & Ran, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-68327-1 · Cited by 42
Endo-phenotyping of COPD patients
Barnes, P. J. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1804364 · Cited by 41
Self-citationPD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma
Jalili‐Nik, M., Soltani, A., Mashkani, B., Rafatpanah, H., & Hashemy, S. I. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107870 · Cited by 41
Ali, L., Wallström, S., Fors, A., Barenfeld, E., Fredholm, E. M., Fu, M. L. X., Goudarzi, M., Gyllensten, H., Kjellberg, I. L., Swedberg, K. B., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/26794 · Cited by 41
Treekitkarnmongkol, W., Hassane, M., Sinjab, A. F., Chang, K., Hara, K., Rahal, Z., Zhang, J., Lü, W., Sivakumar, S., McDowell, T. L., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1079oc · Cited by 42
Papp, C., Pák, K., Erdei, T., Juhász, B., Seres, I., Szentpéteri, A., Kardos, L., Szilasi, M., Gesztelyi, R., & Zsuga, J. (2017) · International Journal of COPD · doi:10.2147/copd.s135701 · Cited by 41
Metadata
- Authors
- Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
- Affiliations
- Philipps University of Marburg (DE)
- Temple University (US)
- New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
- The University of Texas at San Antonio Health Science Center (US)
- Imperial College London (GB)
- McGill University Health Centre (CA)
- Brigham and Women’s Hospital, Boston, Massachusetts
- First Affiliated Hospital of Guangzhou Medical University (CN)
- KU Leuven (BE)
- University of Modena and Reggio Emilia (IT)
- Flinders University (AU)
- Royal Devon and Exeter Hospital (GB)
- Universidad de la República, Hospital Maciel, Montevideo, Uruguay
- Hokkaido University (JP)
- Hôpital Cochin (Assistance Publique–Hôpitaux de Paris), University Paris Descartes, Paris, France
- Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain
- University of British Columbia (CA)
- University Hospital, Birmingham, United Kingdom; and
- University of Manchester (GB)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Corresponding author
- Vogelmeier, Claus F.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-01
- Volume
- 195
- Issue
- 5
- Pages
- 557-582
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2583265473
- Cited by
- 3,187
- References
- 305
- Citations by year
- 2026: 118 · 2025: 162 · 2024: 247 · 2023: 307 · 2022: 415 · 2021: 441 · 2020: 449 · 2019: 436 · 2018: 428 · 2017: 173
- FWCI
- 336.54
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10270, NF-SI-0513-10077, NF-SI-0611-10148)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, GOLD 2017, COPD diagnosis, COPD management, COPD prevention, exacerbations, non-pharmacological treatment, comorbidities, spirometry, symptom assessment
- MeSH terms
- Bronchodilator Agents, Humans, Risk Factors, Spirometry, Global Health, Pulmonary Disease, Chronic Obstructive, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
